[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Approvals - March 2005

  ANDA Number Generic Drug Name Applicant Approval Date
1 76-856 DANTROLENE SODIUM CAPSULES 25 MG, 50 MG, AND 100 MG   IMPAX LABORATORTIES, INC. 3/1/2005 
2 76-943 TORSEMIDE TABLETS 5 MG, 10 MG, AND 20 MG   ROXANE LABORATORIES, INC. 3/1/2005 
3 77-020 CILOSTAZOL TABLETS 100 MG   IVAX PHARMACEUTICALS, INC. 3/1/2005 
4 65-200 GRISEOFULVIN ORAL SUSPENSION, USP 125 MG/5 ML   STIEFEL LABORATORIES, INC. 3/2/2005 
5 74-777 RANITIDINE INJECTION, USP 25 MG/ML; PACKAGED IN 50 MG/2 ML VIALS   BEN VENUE LABORATORIES, INC. 3/2/2005 
6 76-773 MICONAZOLE NITRATE VAGINAL CREAM (3-DAY TREATMENT) (OTC) 4%   TARO PHARMACEUTICALS U.S.A., INC. 3/2/2005 
7 76-803 QUINAPRIL HYDROCHLORIDE TABLETS 5 MG (BASE), 10 MG (BASE), 20 MG (BASE), AND 40 MG (BASE)   EON LABS, INC. 3/2/2005 
8 76-931 BUPRENORPHINE HYDROCHLORIDE INJECTION 0.3 MG (BASE)/ML   BEDFORD LABORATORIES 3/2/2005 
9 77-146 FAMOTIDINE TABLETS, USP (OTC) 10 MG   WOCKHARDT LIMITED 3/7/2005 
10 65-195 CLARITHROMYCIN TABLETS, USP 250 MG AND 500 MG   GENPHARM INC. 3/11/2005 
11 77-150 CILOSTAZOL TABLETS 50 MG   COREPHARMA, LLC 3/11/2005 
12 75-400 FAMOTIDINE TABLETS, USP (OTC) 10 MG   L. PERRIGO COMPANY 3/18/2005 
13 76-959 CARBOPLATIN FOR INJECTION, USP 50 MG, 150 MG, AND 450 MG SINGLE-DOSE VIALS   EON LABS, INC. 3/18/2005 
14 75-477 GABAPENTIN CAPSULES 100 MG, 300 MG, AND 400 MG   IVAX PHARMACEUTICALS, INC. 3/23/2005 
15 40-169 DICYCLOMINE HYDROCHLORIDE SYRUP, USP 10 MG/5 ML   MIKART, INC. 3/24/2005 
16 65-078 CYCLOSPORINE ORAL SOLUTION, USP (MODIFIED) 100 MG/ML   IVAX PHARMACEUTICALS S.R.O. 3/25/2005 
17 76-888 FLUCONAZOLE INJECTION (IN 5% DEXTROSE INJECTION) 2 MG/ML; PACKAGED IN 200 MG/100 ML AND 400 MG/200 ML SINGLE-DOSE PLASTIC CONTAINERS   APOTEX CORP. 3/25/2005 
18 76-889 FLUCONAZOLE INJECTION (IN 0.9% SODIUM CHLORIDE INJECTION) 2 MG/ML; PACKAGED IN 200 MG/100 ML AND 400 MG/200 ML SINGLE-DOSE PLASTIC CONTAINERS   APOTEX CORP. 3/25/2005 
19 77-152 TERBUTALINE SULFATE TABLETS, USP 2.5 MG AND 5 MG   LANNETT HOLDINGS, INC. 3/25/2005 
20 76-313 OCTREOTIDE ACETATE INJECTION (PRESERVATIVE FREE) 0.05 MG/ML, 0.1 MG/ML, AND 0.5 MG/ML   BEFORD LABORATORIES 3/28/2005 
21 77-061 MOMETASONE FUROATE OINTMENT, USP 0.1%   ALTANA INC. 3/28/2005 
22 77-093 QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE TABLETS 10 MG (BASE)/12.5 MG, 20 MG (BASE)/12.5 MG, AND 20 MG (BASE)/25 MG   MYLAN PHARMACEUTICALS, INC. 3/28/2005 
23 65-110 CYCLOSPORINE CAPSULES USP (MODIFIED) 25 MG, 50 MG, AND 100 MG   IVAX PHARMACEUTICALS S.R.O. 3/29/2005 
24 76-951 NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) CAPSULES 100 MG   RANBAXY LABORATORIES LIMITED 3/30/2005 

Back to Top      Back to Approvals

Date created: April 8, 2005

horizonal rule